Cora Gold CEO Bert Monro Talks Through Sanankoro’s Fast-Track to Production and Major Upside Potential
Verge Technologies: Delivering zero-downtime database resilience in a multi-cloud world 28 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Panmure Liberum Highlights Cerillion’s Expanding Pipeline and Strengthening Growth Outlook 1 December 2025
Strix Group Sharpens Focus on Shareholder Value and Debt Reduction – Equity Development 26 November 2025
Hilton Food Group PLC (HFG.L) Stock Analysis: Unpacking a 54% Potential Upside in the Consumer Defensive Sector 6 January 2026
Ashmore Group PLC (ASHM.L) Stock Analysis: Navigating a Challenging Landscape with a 9.66% Dividend Yield 6 January 2026
Cora Gold CEO Bert Monro Talks Through Sanankoro’s Fast-Track to Production and Major Upside Potential
Verge Technologies: Delivering zero-downtime database resilience in a multi-cloud world 28 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Panmure Liberum Highlights Cerillion’s Expanding Pipeline and Strengthening Growth Outlook 1 December 2025
Strix Group Sharpens Focus on Shareholder Value and Debt Reduction – Equity Development 26 November 2025
Hilton Food Group PLC (HFG.L) Stock Analysis: Unpacking a 54% Potential Upside in the Consumer Defensive Sector 6 January 2026
Ashmore Group PLC (ASHM.L) Stock Analysis: Navigating a Challenging Landscape with a 9.66% Dividend Yield 6 January 2026
Open Orphan key considerations document for developing and manufacturing challenge agents published 12 May 2022
Open Orphan no plans to delist, substantial contract with existing top 5 global pharmaceutical client 4 May 2022
Open Orphan proposal to purchase Poolbeg Pharma shares from distribution in specie shareholders 13 April 2022
Poolbeg Pharma strong investor demand is clear vote of confidence in Poolbeg’s prospects 11 April 2022
Open Orphan wins £5m RSV human challenge study contract with European biotechnology company 25 March 2022
Open Orphan client Enanta Pharmaceuticals confirms positive results from human challenge study 17 February 2022
Peter Cruddas CEO CMC Markets: Building a Fintech Powerhouse from London to Sydney (Video) 11 December 2025
XP Factory: Escape Hunt Delivers Record Margins as Boom Battle Bar Fuels Top-Line Growth (Video) 10 December 2025
Elemental Royalty Corporation: Unlocking long-term value through high-impact royalties (Video) 10 December 2025
NB Private Equity Partners: Buybacks, Exits and a Quiet Rebound Investors Are Missing (Video) 24 November 2025
Cora Gold CEO Bert Monro Talks Through Sanankoro’s Fast-Track to Production and Major Upside Potential 2 June 2025
Verge Technologies: Delivering zero-downtime database resilience in a multi-cloud world 28 November 2025
Panmure Liberum Highlights Cerillion’s Expanding Pipeline and Strengthening Growth Outlook 1 December 2025
Strix Group Sharpens Focus on Shareholder Value and Debt Reduction – Equity Development 26 November 2025
Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress 31 December 2025
Hilton Food Group PLC (HFG.L) Stock Analysis: Unpacking a 54% Potential Upside in the Consumer Defensive Sector 6 January 2026
Ashmore Group PLC (ASHM.L) Stock Analysis: Navigating a Challenging Landscape with a 9.66% Dividend Yield 6 January 2026
